Mesoblast gains US FDA OK for Phase III mesenchymal precursor cell study
11 July 2011
Donna Young
Please Login to read the full article.
11 July 2011
Donna Young
donna.young@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Stem cell death for cash-crunched Geron, Angiotech, but Mesoblast outlasts them
- Mesoblast stem cell therapy advances into Phase II for spinal degeneration
- S Korea forges ahead in stem cells as Medipost preps for first allogeneic therapy launch
- US BARDA awards $56.3 million to advance radiation injury treatments
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
